Panacea Life Sciences Holdings, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
Panacea Life Sciences Holdings, Inc. (PLSH) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of -$376 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2024-05-06
- Panacea Life Sciences Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-03-31 was -$376.00.
- Panacea Life Sciences Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2022-09-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2022-06-30 was $22.82K.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month |
|---|---|---|---|
| 2024-03-31 | -$376.00 10-Q · filed 2024-05-06 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $22.82K derived: sum of 2 quarters · filed 2022-11-14 | $22.82K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $22.82K 10-Q · filed 2022-08-15 | $22.82K 10-Q · filed 2022-08-15 |